2-溴丁酸叔丁酯 | 24457-21-4

• 物质功能分类: 化学试剂 - 有机试剂 - 酯类
• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: 2-溴丁酸叔丁酯
• 英文名称: 2-bromobutyric acid tert-butyl ester
• 英文别名: tert-butyl 2-bromobutyrate；tert-Butyl 2-bromobutanoate
• CAS: 24457-21-4
• 化学式: C₈H₁₅BrO₂
• mdl: MFCD00209634
• 分子量: 223.11
• InChiKey: RIUJWUWLGXBICR-UHFFFAOYSA-N

物化性质

• 沸点：
  72-76°C 12mm
• 密度：
  1,2 g/cm3
• 闪点：
  72-76°C/12mm
• 稳定性/保质期：
  如果遵照规格使用和储存则不会分解，避免接触氧化物。

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  11
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.875
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  8
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R36/37/38
• 危险品运输编号：
  UN 3334
• 海关编码：
  2915900090
• 包装等级：
  III
• 危险类别：
  8
• 危险性防范说明：
  P264,P271,P301+P330+P331,P305+P351+P338,P363,P403+P233,P501
• 危险性描述：
  H314

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: tert-Butyl 2-bromobutyrate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H314: Causes severe skin burns and eye damage
H318: Causes serious eye damage
P260: Do not breathe dust/fume/gas/mist/vapours/spray
P303+P361+P353: IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with
water/shower
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P301+P330+P331: IF SWALLOWED: Rinse mouth. Do NOT induce vomiting
P405: Store locked up

---

Section 3. Composition/information on ingredients.
Ingredient name: tert-Butyl 2-bromobutyrate
CAS number: 24457-21-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C8H15BrO2
Molecular weight: 223.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
UN Number: UN1760 Class: 8 Packing group: III
Proper shipping name: CORROSIVE LIQUIDS, N.O.S. (tert-Butyl 2-bromobutyrate)

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

2-溴丁酸叔丁酯是一种羧酸酯类衍生物，可用作有机合成中的重要试剂。

反应信息

• 作为反应物：
  描述：

  2-溴丁酸叔丁酯 在 sodium hydride 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 3.25h， 以72%的产率得到3-(1-tert-butoxycarbonyl-propyl)-5-cyano-2-oxo-2,3-dihydro-benzoimidazole-1-carboxylic acid tert-butyl ester
  参考文献：
  名称：

  WO2008/25736

  摘要：

  公开号：
• 作为产物：
  描述：

  2-溴丁酸 生成 2-溴丁酸叔丁酯
  参考文献：
  名称：

  Cephalosporin compounds

  摘要：

  该专利描述了头孢菌素类化合物的通用公式，其中R表示由公式所示的基团，其中R1表示氢原子或1-3个碳原子的较低烷基基团，R2表示氢原子、1-3个碳原子的较低烷基基团、苯基，该苯基可能被氨基或羟基取代、氰基、羧基或羧甲基基团；其中R1和R2可以与它们所连接的碳原子一起形成4-6个碳原子的环烷基亚基基团，或者是由公式—CH2—R3所示的基团（其中R3表示氢原子、卤代甲基基团、氨基甲酰基团、羧甲基基团、α-4-羧基-3-羟基异噻唑-5-基硫甲基基团或α-2-羧基苯基硫甲基基团）；R'表示由公式所示的基团，其中Ra表示羧基、氰基或者可以被1-3个碳原子的较低烷基基团取代的氨基甲酰基团，Rb表示氢原子或氨基基团；或者是由公式所示的基团（其中Ra和Rb具有与上述相同的意义）；波浪线表示反式键或顺式键，以及它们的盐。这些化合物对革兰氏阳性菌和革兰氏阴性菌，尤其是铜绿假单胞菌具有出色的抗菌活性，并可用作抗菌剂。

  公开号：

  US04474779A1

文献信息

• FACTOR XIA-INHIBITING PYRIDOBENZAZEPINE AND PYRIDOBENZAZOCINE DERIVATIVES
  申请人：BAYER PHARMA AKTIENGESELLSCHAFT

  公开号：US20170275282A1

  公开（公告）日：2017-09-28

  The invention relates to substituted pyridobenzazepine and pyridobenzazocine derivatives and to processes for preparation thereof, and also to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.

  这项发明涉及取代的吡啶苯并脑和吡啶苯并哌啶衍生物，以及其制备方法，还涉及将其用于生产用于治疗和/或预防疾病的药物，特别是心血管疾病，最好是血栓性或血栓栓塞性疾病，水肿，以及眼科疾病。
• The Hydrolysis of Esters Related to <i>O</i>-Hippuryl-2-hydroxybutanoic Acid by Carboxypeptidase A
  作者：John W. Bunting、Joe Murphy

  DOI：10.1139/v74-385

  日期：1974.7.15

  The hydrolysis of each of the following esters by bovine carboxypeptidase A has been studied at pH 7.5, 25°, ionic strength 0.5: O-hippuryl-, O-phenaceturyl-, O-aceturyl-, O-(N-methylhippuryl)-, and O-(N-hippurylglycyl)-2-hydroxybutanoic acids, and 2-(3-benzoylpropanoxy)-, 2-benzoxyacetoxy-, and 2-(4-phenylbutanoxy)butanoic acids. Substrate inhibition occurs with only the hippuric and phenaceturic acid esters and in the six other cases simple Michaelis–Menten kinetics are observed. The relatively minor variations in the structures of the acid moieties of these esters lead to quite large variations in K_m, although k_cat seems to be relatively independent of the nature of the acid moiety. Binding modes of substrate molecules at both the catalytic and inhibitory sites are discussed in the light of these observations.

  以下酯化物在pH 7.5、25°C、离子强度为0.5条件下，通过牛羧肽酶A的水解已经被研究：O-香豆酰基、O-苯乙酰基、O-乙酰基、O-(N-甲基香豆酰基)、O-(N-香豆酰甘氨酰)-2-羟基丁酸，以及2-(3-苯甲酰基丙酰氧基)-、2-苯甲酰基乙酸氧基-和2-(4-苯基丁酰氧基)丁酸。只有香豆酸和苯乙酸酯发生底物抑制，在其他六种情况下观察到简单的米氏-门特氏动力学。这些酯的酸基结构相对较小的变化导致Km有相当大的变化，尽管kcat似乎与酸基的性质相对独立。在这些观察结果的光下，讨论了底物分子在催化和抑制位点的结合模式。
• PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME
  申请人：ABIDE THERAPEUTICS, INC.

  公开号：US20190202801A1

  公开（公告）日：2019-07-04

  Provided herein are piperazine carbamates and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of MAGL and/or ABHD6. Furthermore, the subject compounds and compositions are useful for the treatment of pain.

  本文提供了哌嗪氨基甲酸酯和包含该化合物的药物组合物。所述化合物和组合物可用作MAGL和/或ABHD6的调节剂。此外，所述化合物和组合物可用于治疗疼痛。
• DERIVATIVES OF SUBSTITUTED 3-PHENYL-1-(PHENYLTHIENYL)PROPAN-1-ONES AND OF 3-PHENYL-1-(PHENYLFURANYL) PROPAN-1-ONES, PREPARATION AND USE
  申请人：Delhomel Jean-Francois

  公开号：US20100029745A1

  公开（公告）日：2010-02-04

  The present invention relates to compounds derived from substituted 3-phenyl-1-(thien-2-yl)propan-1-ones, pharmaceutical compositions comprising them as well as their therapeutic applications, notably in the field of human and animal health.

  这项发明涉及从取代的3-苯基-1-(噻吩-2-基)丙酮衍生的化合物，包括它们的药物组合物以及它们在人类和动物健康领域的治疗应用，特别是治疗应用。
• Substituted Oxopyridine Derivatives and Use Thereof in the Treatment of Cardiovascular Disorders
  申请人：BAYER PHARMA AKTIENGESELLSCHAFT

  公开号：US20160052884A1

  公开（公告）日：2016-02-25

  The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.

  这项发明涉及替代的氧代吡啶衍生物及其制备方法，以及它们用于制备用于治疗和/或预防疾病的药物，特别是心血管疾病，优选是血栓性或血栓栓塞性疾病、水肿以及眼科疾病。